Antisense oligonucleotides
There are few disease-modifying therapeutics for neurodegenerative diseases, but successes on the development of antisense oligonucleotide (ASO) therapeutics for spinal muscular atrophy and Duchenne muscular dystrophy predict a robust future for ASOs in medicine. Indeed, existing pipelines for the d...
-д хадгалсан:
| Үндсэн зохиолчид: | , , |
|---|---|
| Формат: | Revisão |
| Хэл сонгох: | англи |
| Хэвлэсэн: |
2019
|
| Онлайн хандалт: | https://doi.org/10.1212/nxg.0000000000000323 https://ng.neurology.org/content/nng/5/2/e323.full.pdf |
| Шошгууд: |
Шошго нэмэх
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|